Ignite Creation Date:
2024-05-06 @ 2:34 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04355520
Status:
UNKNOWN
Last Update Posted:
2020-04-21
First Post:
2020-04-20
Brief Title:
A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive HER2-negative and PIK3CA Mutation Advanced Breast Cancer
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Organization Data
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Class:
INDUSTRY
Study ID:
TQ-B3525-I-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None